Related Experiment Video
Updated: Jun 15, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway
Myoung Shin Kim1, Seung Kew Yoon, Frank Bollig
1Genetics of Development and Disease Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
Mammalian kidney development requires the functions of the Wilms tumor gene WT1 and the WNT/beta-catenin signaling pathway. Recent studies have shown that WT1 negatively regulates WNT/beta-catenin signaling, but the molecular mechanisms by which WT1 inhibits WNT/beta-catenin signaling are not completely understood. In this study, we identified a gene, CXXC5, which we have renamed WID (WT1-induced Inhibitor of Dishevelled), as a novel WT1 transcriptional target that negatively regulates WNT/beta-catenin signaling. WT1 activates WID transcription through the upstream enhancer region. In the developing kidney, Wid and Wt1 are coexpressed in podocytes of maturing nephrons. Structure-function analysis demonstrated that WID interacts with Dishevelled via its C-terminal CXXC zinc finger and Dishevelled binding domains and potently inhibits WNT/beta-catenin signaling in vitro and in vivo. WID is evolutionarily conserved, and ablation of wid in zebrafish embryos with antisense morpholino oligonucleotides perturbs embryonic kidney development. Taken together, our results demonstrate that the WT1 negatively regulates WNT/beta-catenin pathway via its target gene WID and further suggest a role for WID in nephrogenesis.
Insights
The Wilms tumor gene WT1 inhibits kidney development pathways by activating WID. This WT1-induced Inhibitor of Dishevelled (WID) protein then blocks WNT/beta-catenin signaling, crucial for nephrogenesis.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- Mammalian kidney development relies on Wilms tumor gene WT1 and WNT/beta-catenin signaling.
- WT1 is known to negatively regulate WNT/beta-catenin signaling, but the precise mechanisms remain unclear.
Purpose of the Study:
- To identify novel WT1 target genes involved in regulating WNT/beta-catenin signaling.
- To elucidate the molecular mechanisms by which WT1 inhibits this pathway during kidney development.
Main Methods:
- Gene identification and renaming (CXXC5 to WID).
- Analysis of WT1 binding to the WID enhancer region.
- Structure-function studies of WID protein interaction with Dishevelled.
- In vitro and in vivo inhibition assays of WNT/beta-catenin signaling.
- Zebrafish embryo studies using antisense morpholino oligonucleotides to ablate WID.
Main Results:
- CXXC5, renamed WID (WT1-induced Inhibitor of Dishevelled), was identified as a novel WT1 transcriptional target.
- WT1 activates WID transcription via an upstream enhancer.
- WID interacts with Dishevelled (Dvl) and inhibits WNT/beta-catenin signaling both in vitro and in vivo.
- WID is evolutionarily conserved.
- Ablation of WID in zebrafish embryos disrupted kidney development.
Conclusions:
- WT1 negatively regulates the WNT/beta-catenin pathway through its target gene, WID.
- WID plays a significant role in mammalian nephrogenesis.
- This study reveals a new regulatory axis in kidney development involving WT1, WID, and WNT/beta-catenin signaling.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation